BN Business News
Add your company to Business Communicator →

Business · 10/06/2015

FDA Releases Draft Guidance for Duchenne Muscular Dystrophy Treatment Drugs

The FDA is releasing a draft guidance to help pharmaceutical companies develop drugs for treating X-linked Duchenne muscular dystrophy and related conditions

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights